Polaryx Therapeutics, Inc. (PLYX)

NASDAQ

$1.90

$-0.02

(-1.04%)

Previous Close: ⁦$1.92⁩

Market Closed

Polaryx Therapeutics, Inc. (PLYX) Live Price Chart

Last updated: ⁦2026-10-21 07:22:20⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Polaryx Therapeutics, Inc. (PLYX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.90, with a market capitalization of $95.70M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.83 to $48.91. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$95.70M
Open	$1.89
Day's High	$48.91
Day's Low	$1.83
Previous Close	$1.92
Volume	7.18K
Average Volume	68.31K
P/E Ratio	--
52-Week High	$48.91
52-Week Low	$1.83
Dividend Yield	--
Earnings Date	--

Polaryx Therapeutics, Inc. (PLYX) Latest Closing Stock Price

Polaryx Therapeutics, Inc. (PLYX) last closed at $1.92 as of 2026-10-21 00:00:00, unchanged from the previous close of $1.92.

During the latest regular trading session, PLYX traded between $1.83 and $48.91, with a volume of 7.18K shares. The closing price was near the lower end and near the lower end of its 52-week range.

Polaryx Therapeutics, Inc. (PLYX) 7-Day Stock Price Change

Over the past seven days, Polaryx Therapeutics, Inc. (PLYX) moved from $2.01 to $1.90, representing a decline of 5.27% ($0.11).

The stock traded between $1.83 and $2.05 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.

The average daily volume was 21.36 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

PLYX 52-Week Price Position

Position in Range: 0.2%

52W Low$1.83

52W High$48.91

PLYX is currently trading at $1.90, placing it 0.2% of the way from its 52-week low of $1.83 to its 52-week high of $48.91. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Polaryx Therapeutics, Inc. (PLYX)?

Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the underlying pathophysiology of these diseases and addressing unmet needs. The company's therapeutic pipeline includes PLX-200, PLX-300, and PLX-100, which are orally available small-molecule drug candidates designed to address core pathological mechanisms common to LSDs. The Company has one reportable segment: lysosomal storage disorders. The lysosomal storage disorders segment consists of the Company's costs associated with the preclinical and clinical development of the Company's product candidates.

Polaryx Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Exchange	NASDAQ
Company Website	https://www.polaryx.com

How to Buy Polaryx Therapeutics, Inc. (PLYX) Stock on MEXC

Eligible investors can buy real shares of Polaryx Therapeutics, Inc. (PLYX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for PLYX and Place Your Order

Open the RealStocks trading page and search for PLYX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Polaryx Therapeutics, Inc. (PLYX) stock price today?

Polaryx Therapeutics, Inc. (PLYX) is currently trading at $ 1.90, down 0.83% ($0.02) from the previous close of $ 1.92. Intraday prices update in real time during regular trading hours.

2.Is PLYX stock going up or down today?

As of 2026-10-21 00:00:00, PLYX is trading at $ 1.90, down 0.83% ($0.02) from its previous close of $ 1.92. The stock has traded between $ 1.83 and $ 48.91 during today’s regular session. Past price movements do not guarantee future results.

3.What is PLYX pre-market price?

As of 2026-10-21 00:00:00, PLYX is trading at $ 1.93 in pre-market trading, up 0.26% ($0.01) from the previous close of $ 1.92. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is PLYX after-hours price?

As of 2026-10-21 00:00:00, PLYX is trading at $ 1.91 in after-hours trading, down 0.78% ($0.01) from the regular-session close of $ 1.92. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is PLYX stock trading now?

PLYX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does PLYX sit relative to its 52-week high and low?

Over the past 52 weeks, PLYX has traded between a low of $ 1.83 and a high of $ 48.91. At $ 1.90, the stock is positioned 0.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Polaryx Therapeutics, Inc. in?

Polaryx Therapeutics, Inc. (PLYX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Polaryx Therapeutics, Inc.'s market capitalization and where is it listed?

Polaryx Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 95.70M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is PLYX valued in terms of P/E ratio and EPS?

PLYX trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Polaryx Therapeutics, Inc. pay a dividend?

Polaryx Therapeutics, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.